CoChat

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses

Open access

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Abstract

Background: Clozapine remains the only evidence-based antipsychotic for treatment-resistant schizophrenia (TRS). The ability to predict which patients with their first onset of schizophrenia would subsequently meet criteria for treatment resistance (TR) could help to diminish the severe functional disability which may ensue if TR is not recognized and correctly treated. Method: This is a 5-year longitudinal assessment of clinical outcomes in a cohort of 246 first-episode schizophrenia spectrum patients recruited as part of the NIHR Genetics and Psychosis (GAP) study conducted in South London from 2005 to 2010. We examined the relationship between baseline demographic and clinical measures and the emergence of TR. TR status was determined from a review of electronic case records. We assessed for associations with early-, and late-onset TR, and non-TR, and differences between those TR patients treated with clozapine and those who were not. Results: Seventy per cent ( n = 56) of TR patients, and 23% of the total study population ( n = 246) were treatment resistant from illness onset. Those who met criteria for TR during the first 5 years of illness were more likely to have an early age of first contact for psychosis (<20 years) [odds ratio (OR) 2.49, 95% confidence interval (CI) 1.25–4.94] compared to those with non-TR. The relationship between an early age of first contact (<20 years) and TR was significant in patients of Black ethnicity (OR 3.71, 95% CI 1.44–9.56); and patients of male gender (OR 3.13 95% CI 1.35–7.23). Conclusions: For the majority of the TR group, antipsychotic TR is present from illness onset, necessitating increased consideration for the earlier use of clozapine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0033291716002014

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 2

  1. 1994, Schedules for Clinical Assessment in Neuropsychiatry: Version 2: Manual
  2. 1992, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines

Cited by

See all 298

Metadata

Authors
Lally, J., Ajnakina, O., Di Forti, M., Trotta, A., Demjaha, A., Kolliakou, A., Mondelli, V., Reis Marques, T., Pariante, C., Dazzan, P., Shergil, S. S., Howes, O. D., David, A. S., MacCabe, J. H., Gaughran, F., & Murray, R. M.
Affiliations
  • National Health Service (GB)
  • King's College London (GB)
Corresponding author
Lally, J.
Venue
Psychological Medicine
Published
2016-09-08
Volume
46
Issue
15
Pages
3231-3240
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W2517254183
Cited by
298
References
51
Citations by year
2026: 34 · 2025: 26 · 2024: 31 · 2023: 29 · 2022: 34 · 2021: 36 · 2020: 32 · 2019: 33 · 2018: 29 · 2017: 12 · 2016: 2
FWCI
22.51
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by-nc-sa)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • Eli Lilly and Company
  • Sunovion
  • Psychiatry Research Trust
  • National Institute for Health and Care Research (CL-2008-17-005, Grant Reference Number RP-PG-0606-1049, NF-SI-0512-10110, 0606-1049, RP-PG-0606-1049, PG-0606-1049)
  • Academy of Medical Sciences (AMS-SGCL5-Mondelli)
  • King's College London
  • Servier
  • H. Lundbeck A/S
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London
  • Medical Research Council (MR/L003988/1, MR/K004867/1, MR/L011794/1, MR/K013807/1)
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
treatment-resistant schizophrenia, first-episode psychosis, schizophrenia spectrum disorders, clozapine, early-onset psychosis, clinical predictors, Black ethnicity, sex differences, antipsychotic treatment resistance, functional disability
MeSH terms
Adult, Age Factors, Clozapine, Drug Resistance, Female, Humans, London, Longitudinal Studies, Male, Psychotic Disorders, Risk Factors, Schizophrenia, Schizophrenic Psychology, Sex Factors, Antipsychotic Agents, Odds Ratio, Black People, White People, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. https://app.cochat.ai/papers/10.1017/s0033291716002014
The paper
Lally, J., Ajnakina, O., Di Forti, M., Trotta, A., Demjaha, A., Kolliakou, A., Mondelli, V., Reis Marques, T., Pariante, C., Dazzan, P., Shergil, S. S., Howes, O. D., David, A. S., MacCabe, J. H., Gaughran, F., & Murray, R. M. (2016). Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychological Medicine. https://doi.org/10.1017/s0033291716002014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.